Picture of AbCellera Biologics logo

ABCL — AbCellera Biologics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Abcellera Biologics Inc reports results for the quarter ended in June - Earnings Summary

* Abcellera Biologics Inc  ABCL.OQ  reported a quarterly
adjusted
loss of 13 cents​​ per share for the quarter ended in June,
lower than the same quarter last year, when the company reported
EPS of -11 cents.  The mean expectation of nine analysts for the
quarter was for a loss of 14 cents per share. Wall Street
expected results to range from -16 cents to -13 cents per share.
    * Revenue fell 27.2% to $7.32 million from a year ago;
analysts
expected $10.15 million. 
    * Abcellera Biologics Inc's reported EPS for the quarter was
a
loss of 13 cents​.
    * The company reported a quarterly loss of $36.93 million.
    * Abcellera Biologics Inc shares had fallen by 6.8% this
quarter and lost 51.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 11.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Abcellera
Biologics Inc is $14.50 
This summary was machine generated from LSEG data August 6 at
10:55 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.14          -0.13          Beat
 Mar. 31 2024      -0.17          -0.14          Beat
 Dec. 31 2023      -0.13          -0.17          Missed
 Sep. 30 2023      -0.13          -0.10          Beat

Recent news on AbCellera Biologics

See all news